Ampligene India Biotech Private Limited, a active private limited company, was established on 18 September 2012 in Ahmedabad, Gujarat, India. Engaging in industrial machinery retail & distribution within the trade sector, it holds CIN: U52100GJ2012PTC072019. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Nirupama Ramkrishna Pandya (Director), Deepal Pandya (Director), Chirag Ramkrishna Pandya (Director). Past directors included Megha Devnani Jitendra, Chirag Ramkrishna Pandya. Its latest AGM occurred on 20 September 2024, with the balance sheet filed on 31 March 2024. It is based at 4Th F/401,Ashwamegh Elegance -2, Nr Chhabada Building Near Central Mall A, Mbawadi, Ahmedabad, Gujarat, 380006.
U52100GJ2012PTC072019
072019
18 September 2012
₹1.00 M
₹1.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Ampligene India Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirupama Ramkrishna Pandya | Director | 18 Sep 2012 | Current |
| Deepal Pandya | Director | 08 Dec 2012 | Current |
| Chirag Ramkrishna Pandya | Director | 17 Jul 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Aug 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ampligene India Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 224.01% increase. The company also saw a substantial improvement in profitability, with a 45.06% increase in profit. The company's net worth Soared by an impressive increase of 46.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Ampligene India Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ampligene India Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ampligene India Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ampligene India Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Ampligene India Biotech Private Limited last Annual general meeting of members was held on 20 Sep 2024 as per latest MCA records. was documented.
Progress on Ampligene India Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.
The activity Chirag Ramkrishna Pandya was appointed as a Director was appointed as a Director on 17 Jul 2018 & has been associated with this company since 7 years 5 months . was completed.
Deepal Pandya was appointed as a Director was appointed as a Director on 08 Dec 2012 & has been associated with this company since 13 years 24 days . was recorded as a recent event.
The activity Nirupama Ramkrishna Pandya was appointed as a Director was appointed as a Director on 18 Sep 2012 & has been associated with this company since 13 years 3 months . was completed.
The activity Ampligene India Biotech Private Limited was registered on 18 Sep 2012 with Roc Ahmedabad & aged 13 years 3 months as per MCA records. was completed.
The CIN of Ampligene India Biotech Private Limited is U52100GJ2012PTC072019.
Ampligene India Biotech Private Limited is headquartered at 4Th F/401,Ashwamegh Elegance -2, Nr Chhabada Building Near Central Mall A, Mbawadi, Ahmedabad, Gujarat, 380006.
Ampligene India Biotech Private Limited was incorporated on 18 September 2012.
The current directors of Ampligene India Biotech Private Limited are
The primary industry of Ampligene India Biotech Private Limited is Trade.
Ampligene India Biotech Private Limited is unlisted.
The authorized capital of Ampligene India Biotech Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Ampligene India Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX